Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation

Background Patients with atrial fibrillation (AF) face an increased risk of death and major adverse cardiovascular events (MACE). We aimed to assess the predictive value of the novel atrial‐specific biomarker BMP10 (bone morphogenetic protein 10) for death and MACE in patients with AF in comparison...

詳細記述

書誌詳細

主要な著者:	Elisa Hennings, Steffen Blum, Stefanie Aeschbacher, Michael Coslovsky, Sven Knecht, Ceylan Eken, Mirko Lischer, Rebecca E. Paladini, Philipp Krisai, Tobias Reichlin, Nicolas Rodondi, Jürg H. Beer, Peter Ammann, Giulio Conte, Maria Luisa De Perna, Richard Kobza, Manuel R. Blum, Matthias Bossard, Peter Kastner, André Ziegler, Christian Müller, Leo H. Bonati, Otmar Pfister, Christine S. Zuern, David Conen, Michael Kühne, Stefan Osswald
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2023-03-01
シリーズ:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:	atrial fibrillation BMP10 bone morphogenetic protein 10 death MACE
オンライン･アクセス:	https://www.ahajournals.org/doi/10.1161/JAHA.122.028255
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!